At the GGD in Ams­ter­dam and Utrecht, hun­dreds of peo­ple are on the wait­list for HIV pre­ven­tion pills and some have report­ed­ly become infect­ed while wait­ing, accord­ing to AT5. The GGD is cur­rent­ly look­ing at ways to bet­ter serve patients.

In Ams­ter­dam, the wait­list for the GGD’s PrEP pro­gram stretch­es to 500 peo­ple and the pro­gram has been full since last autumn, said the head of the Cen­ter for Sex­u­al Health. Around 20 peo­ple per week sign up for the PrEP pro­gram online. In Utrecht, the AD reports that 300 peo­ple are cur­rent­ly on the GGD’s wait­ing list to receive pills pre­vent­ing an HIV infec­tion, and some became infect­ed with the virus while wait­ing.
“Access to PrEP in the Nether­lands is still not well orga­nized and that is a missed oppor­tu­ni­ty,” said Bert Her­berigs of the Aids­fonds. “This drug is essen­tial to reduce the num­ber of infec­tions and saves costs in health­care. Because PrEP pre­vents life­long treat­ment for an HIV infec­tion.”

Patients in the GGD’s pro­gram are giv­en free tests for HIV and oth­er STIs every three months, as well as dis­count­ed access to PrEP pills. These tablets mit­i­gate the risk of being infect­ed with HIV.
The Ams­ter­dam GGD is cur­rent­ly inves­ti­gat­ing look­ing into trans­fer­ring some of its most sta­ble patients to gen­er­al prac­ti­tion­ers. “GPs can and want to take over this. The GGD is there for the most vul­ner­a­ble peo­ple,” the Ams­ter­dam GGD said.

How­ev­er, Monique Roe­doe of the LHV med­ical trade asso­ci­a­tion told AD that some­times gen­er­al prac­ti­tion­ers are not qual­i­fied for this. “The solu­tion to this prob­lem does not lie with the gen­er­al prac­ti­tion­er,” Roe­doe said. “PrEP is not part of the stan­dard offer. This is real­ly the respon­si­bil­i­ty of the GGD. Our view is that the major­i­ty of our mem­bers do not pro­vide this care.

(bron: NL Times 10/04/2022)

Last updated 11/04/2022